Smolarz Beata, Wójcik Luiza, Romanowicz Hanna
Laboratory of Cancer Genetics, Department of Pathology, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.
Prz Menopauzalny. 2020 Dec;19(4):160-170. doi: 10.5114/pm.2020.101945. Epub 2021 Jan 7.
To analyze six single nucleotide polymorphisms (SNPs): rs1520220, rs2945834, rs5747694, rs6214, rs6219, rs5742678. An attempt was made to assess the significance of the above gene polymorphisms as prognostic and predictive factors in Polish women with diagnosed increased breast mammographic density.
The study included women diagnosed with an increased breast mammographic density ( = 98), breast cancer ( = 135) and women as a control group ( = 60). The method used to detect polymorphisms in the gene was the analysis of single-stranded DNA conformation polymorphism (SSCP-PCR) and Sanger's sequencing.
In the case of rs1520220 polymorphism, the genotype CC was found to increase the risk of breast cancer (OR = 2.6 95% CI 1.01-6.5, = 0.04). Analysis of the rs2945834 polymorphism revealed that the occurrence of the G allele reduced the risk of breast cancer, while the occurrence of the A allele increased the risk of disease almost twice (OR = 0.55 95% CI). Among women who are heterozygous in terms of rs5747694 polymorphism (TG), the risk of breast cancer is twice as high as in the control group. The SNPs in the study group did not correlate with mammographic breast density.
The results obtained in the course of the analysis indicate that polymorphisms rs1520220, rs2946834, rs5747694 gene are associated with the occurrence of breast cancer but not with increased mammographic density. Summing up, the association between the polymorphisms of and the risk of developing breast cancer is independent of mammographic density.
分析六个单核苷酸多态性(SNP):rs1520220、rs2945834、rs5747694、rs6214、rs6219、rs5742678。旨在评估上述基因多态性作为波兰乳腺钼靶密度增加确诊女性的预后和预测因素的意义。
该研究纳入了乳腺钼靶密度增加确诊女性(n = 98)、乳腺癌患者(n = 135)以及作为对照组的女性(n = 60)。用于检测该基因多态性的方法是单链DNA构象多态性分析(SSCP-PCR)和桑格测序。
对于rs1520220多态性,发现基因型CC会增加患乳腺癌的风险(OR = 2.6,95%CI 1.01 - 6.5,P = 0.04)。rs2945834多态性分析显示,G等位基因的出现降低了患乳腺癌的风险,而A等位基因的出现使疾病风险增加近两倍(OR = 0.55,95%CI)。在rs5747694多态性杂合(TG)的女性中,患乳腺癌的风险是对照组的两倍。研究组中的SNP与乳腺钼靶密度无关。
分析过程中获得的结果表明,rs1520220、rs2946834、rs5747694基因多态性与乳腺癌的发生相关,但与乳腺钼靶密度增加无关。总之,该基因多态性与患乳腺癌风险之间的关联独立于乳腺钼靶密度。